M28 Capital Management as of Sept. 30, 2023
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 11 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 46.4 | $41M | 7.0M | 5.75 | |
| Adagio Therapeutics (IVVD) | 18.0 | $16M | 9.2M | 1.70 | |
| Rocket Pharmaceuticals (RCKT) | 12.3 | $11M | 523k | 20.49 | |
| Springworks Therapeutics (SWTX) | 5.2 | $4.6M | 198k | 23.12 | |
| Silence Therapeutics Ads (SLN) | 4.1 | $3.6M | 364k | 9.82 | |
| Bridgebio Pharma (BBIO) | 3.7 | $3.2M | 121k | 26.37 | |
| Curis Com New (CRIS) | 3.2 | $2.8M | 422k | 6.59 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.8 | $2.5M | 1.9M | 1.30 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.1 | $1.8M | 67k | 26.87 | |
| Tg Therapeutics (TGTX) | 2.1 | $1.8M | 217k | 8.36 | |
| Neximmune | 0.0 | $28k | 133k | 0.21 |
